Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | HTR2A | P28223 | 2/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1880314 | 0.98 | LMNA (0.36) | LMNAHTR2AHRH1MEN1KMT2A | |
| Bromide SCHEMBL2835014 | 0.98 | LMNA (0.36) | LMNAHTR2AHRH1MEN1KMT2A | |
| Bromide SCHEMBL22265217 | 0.97 | LMNA (0.35) | LMNAHTR2AHRH1MEN1KMT2A | |
| SCHEMBL2832101 | 0.94 | LMNA (0.34) | LMNAHTR2AHRH1MEN1KMT2A | |
| SCHEMBL5297040 | 0.91 | LMNA (0.32) | LMNA | |
| SCHEMBL5303167 | 0.89 | LMNA (0.30) | LMNAPOLB | |
| SCHEMBL5302234 | 0.89 | HPGD (0.32) | LMNATSHRPOLB | |
| Trifluoromethanesulfonic Acid SCHEMBL2830948 | 0.85 | KCNH2 (0.34) | KMT2A | |
| SCHEMBL28332725 | 0.81 | GABBR2 (0.39) | MEN1KMT2APOLBTDP1 | |
| Bromide SCHEMBL22265218 | 0.80 | HKDC1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1984438-B2 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2016-05-18 | — | — | EP | claimed |
| US-20150057388-A1 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2015-02-26 | — | — | US | claimed |
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | claimed |
| WO-2012130803-A1 | METHOD FOR SEPARATING OFF HALOGENS FROM MIXTURES OF MATTER | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2012-10-04 | — | — | WO | claimed |
| JP-4794561-B2 | — | — | 2011-10-19 | — | — | JP | claimed |
| WO-2010125302-A1 | USE OF IONIC LIQUID FOR THE PERMANENT SHAPING OF KERATINIC FIBRES | L'OREAL (FR) | 2010-11-04 | — | — | WO | claimed |
| EP-1984438-B1 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2010-03-31 | — | — | EP | claimed |
| US-7659430-B2 | Method for separating hydrogen chloride and phosgene | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-09 | — | — | US | claimed |
| US-20090300946-A1 | ANTISTATIC POLYURETHANE | BASF SE (DE) | 2009-12-10 | — | — | US | claimed |
| EP-1789160-B1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF SE (DE) | 2009-11-18 | — | — | EP | claimed |
| US-20070293707-A1 | Method for Separating Hydrogen Chloride and Phosgene | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-20 | — | — | US | claimed |
| WO-2007090755-A1 | ANTISTATIC POLYURETHANE | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-16 | — | — | WO | claimed |
| EP-1812382-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | claimed |
| EP-1805206-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | Combimatrix Corporation (US) | 2007-07-11 | — | — | EP | claimed |
| EP-1789160-A1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-30 | — | — | EP | claimed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | claimed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | claimed |
| WO-2006048171-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | claimed |
| WO-2006029788-A1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-23 | — | — | WO | claimed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293707-A1 | Method for Separating Hydrogen Chloride and Phosgene | PSPH, SLC9B2, HVCN1 | LMNA 3631/4885HTR2A 2213/4885HRH1 479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.